Lilian Pinto da Silva, M. B. Seixas, Ana Paula Delgado Bomtempo Batalha, Isabela Coelho Ponciano, P. Oh, Gabriela L. M. Ghisi
{"title":"在巴西COVID-19大流行期间对糖尿病和前驱糖尿病患者进行随机对照试验所面临的多层次障碍和吸取的教训","authors":"Lilian Pinto da Silva, M. B. Seixas, Ana Paula Delgado Bomtempo Batalha, Isabela Coelho Ponciano, P. Oh, Gabriela L. M. Ghisi","doi":"10.4322/2675-9977.cpcr.42516","DOIUrl":null,"url":null,"abstract":"This an Open Access article published and distributed under a Creative Commons Attribution NonComercial ShareAlike License which permits unrestricted non-commercial use, distribution, and reproduction in any medium provided the original work is properly cited and is not represented as endorsing the use made of the work. Further, any new works must be made available under the same license. Multi-level barriers faced and lessons learned to conduct a randomized controlled trial in patients with diabetes and prediabetes during the COVID-19 pandemic in Brazil","PeriodicalId":164984,"journal":{"name":"Cardiorespiratory Physiotherapy, Critical Care and Rehabilitation","volume":"04 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"Multi-level barriers faced and lessons learned to conduct a randomized controlled trial in patients with diabetes and prediabetes during the COVID-19 pandemic in Brazil\",\"authors\":\"Lilian Pinto da Silva, M. B. Seixas, Ana Paula Delgado Bomtempo Batalha, Isabela Coelho Ponciano, P. Oh, Gabriela L. M. Ghisi\",\"doi\":\"10.4322/2675-9977.cpcr.42516\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"This an Open Access article published and distributed under a Creative Commons Attribution NonComercial ShareAlike License which permits unrestricted non-commercial use, distribution, and reproduction in any medium provided the original work is properly cited and is not represented as endorsing the use made of the work. Further, any new works must be made available under the same license. Multi-level barriers faced and lessons learned to conduct a randomized controlled trial in patients with diabetes and prediabetes during the COVID-19 pandemic in Brazil\",\"PeriodicalId\":164984,\"journal\":{\"name\":\"Cardiorespiratory Physiotherapy, Critical Care and Rehabilitation\",\"volume\":\"04 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1900-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cardiorespiratory Physiotherapy, Critical Care and Rehabilitation\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4322/2675-9977.cpcr.42516\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiorespiratory Physiotherapy, Critical Care and Rehabilitation","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4322/2675-9977.cpcr.42516","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Multi-level barriers faced and lessons learned to conduct a randomized controlled trial in patients with diabetes and prediabetes during the COVID-19 pandemic in Brazil
This an Open Access article published and distributed under a Creative Commons Attribution NonComercial ShareAlike License which permits unrestricted non-commercial use, distribution, and reproduction in any medium provided the original work is properly cited and is not represented as endorsing the use made of the work. Further, any new works must be made available under the same license. Multi-level barriers faced and lessons learned to conduct a randomized controlled trial in patients with diabetes and prediabetes during the COVID-19 pandemic in Brazil